Evaluation of NF2-associated tumors has been limited to date, but one study showed PD-L1 expression (> 5% of tumor cells) in a substantial subset of NF2-associated schwannomas, suggesting that this may be an interesting avenue for further clinical study [73]. The gene discussed is NF2; the disease is neoplasm.